BEST Penny Stocks to Watch
Here is a group of low price penny stocks that have something special. That could include game changing technology or insider buying.
Best Low Price Stocks To WATCH
We are constantly scanning for low price companies that either have game changing technology OR may have unusually large amount of insider buying.
Here are some ones that we found of interest.
These are considered HIGHLY SPECULATIVE companies.
Companies that are highlighted in BLUE are clients.
Disclaimer: The information provided regarding stocks is for informational and educational purposes only and should not be construed as financial advice or a recommendation to buy, sell, or hold any securities. We are not financial advisors, and the content does not account for your individual financial situation or investment goals. Investing in stocks involves risks, and you should consult a qualified financial professional and conduct your own research before making any investment decisions. We assume no liability for any losses or damages arising from the use of this information.
ALUR Allurion Technologies
ALUR helps people lose weight using a swallowable medical balloon instead of surgery.
Allurion Technologies is a medical technology company focused on non-surgical weight loss solutions. Its flagship gastric balloon system is swallowed like a capsule and works alongside digital health coaching and software monitoring.
The company is positioned within the expanding global obesity and metabolic health market.
AMFN American Fusion
Their Texatron™ aneutronic fusion could LEAPFROG nuclear power
AMFN is developing fusion energy technology designed to produce massive amounts of clean power for AI infrastructure, defense, and future energy grids.
American Fusion is an advanced energy company focused on developing aneutronic fusion technology through its Texatron™ platform.
The company is positioning itself around the growing global demand for high-density power driven by AI data centers, defense systems, and next-generation infrastructure. AMFN has recently highlighted government engagement, defense procurement activity, SEC reporting milestones, and strategic supply chain discussions tied to fusion fuel development.
Investors are watching AMFN as a speculative fusion energy play connected to the long-term future of power generation and AI infrastructure demand.
CEIN Camber Energy
CEIN is trying to modernizing the grid: Broken Conductor Protection (BCPT)
Camber’s primary contribution to grid modernization is its patented Broken Conductor Protection Technology.
CHUC Charlie’s Holdings
MULTIPLE CLUSTER INSIDER BUYING
CHUC owns avery large flavored vape PMTA portfolio (imputed value over $650M) that could become highly valuable now that the FDA approved flavored vape PMTAs.
The company has become increasingly watched due to its portfolio of FDA-filed flavored vape PMTAs
Here is how the FDA Decision could impact CHUC
Big Tobacco has quietly started to acquire CHUC PMTAs
The company has also reported strong recent revenue growth and profitability improvements while pursuing potential exchange uplisting plans.
IDAI T Stamp Inc
IDAI uses artificial intelligence to verify identities and stop fraud before it happens.
T Stamp develops AI-powered biometric identity solutions for governments, banks, fintech companies, and security systems.
Its technology analyzes facial biometrics and trust-based AI models to help verify users while reducing fraud risks. Investors see IDAI as an emerging player in the growing AI cybersecurity and digital identity market.
IPWR Ideal Power
INSIDER BUYING
IPWR develops technology that reduces wasted electricity and heat in high-power electronic systems.
Ideal Power is a semiconductor technology company behind B-TRAN™, a patented power switch designed to improve efficiency in electric vehicles, renewable energy systems, AI data centers, and industrial power infrastructure.
The company’s technology aims to reduce friction from electricity flow, potentially lowering energy loss and cooling costs. Bulls believe a major licensing or manufacturing partnership could significantly expand adoption.
LEXX Lexaria Biosciences
LEXX is developing technology designed to help drugs absorb into the body faster and more efficiently.
Lexaria Bioscience is a biotechnology company focused on its patented DehydraTECH™ drug delivery platform, which improves how active ingredients enter the bloodstream. The company is targeting major markets including GLP-1 obesity drugs, nicotine, cannabinoids, and pharmaceutical delivery. Investors are watching LEXX because its technology could potentially improve oral drug performance without creating entirely new drugs.
Bulls see it as a licensing/IP play tied to the exploding obesity-drug market.
LIXT Lixte Biotechnology
LIXT is developing drugs designed to stop cancer cells from repairing themselves, making chemotherapy and immunotherapy work harder.
The company is essentially trying to “turn off cancer’s survival switch.”
Cancer cells normally use repair mechanisms to recover after being damaged by treatment. LIXT’s approach attempts to block that recovery process, forcing damaged cancer cells to continue dividing until they die
If the science works, treatments that already exist may suddenly become much more powerful against resistant cancers
PMEDF QScreen AI
PMEDF uses AI-powered screening technology to detect health risks, impairment, and potential illness before problems become visible
QScreen AI is a healthcare technology company developing artificial intelligence systems for workplace safety, health screening, and early detection monitoring.
Formerly known as Predictmedix AI, the company focuses on AI-powered scanning stations capable of identifying impairment, infectious illness symptoms, fatigue, and mental health indicators using facial analysis and behavioral data
Investors are watching PMEDF because it sits at the intersection of AI, health surveillance, workplace safety, and preventative healthcare technology
PRSO Peraso Inc
They are building a unique wireless network.
PRSO develops ultra-fast wireless technology designed for next-generation communications.
Peraso develops mmWave wireless chips and semiconductor solutions for high-speed internet, military communications, fixed wireless access, and advanced networking systems.
The company’s technology is designed to move large amounts of data quickly with low latency. Investors are watching PRSO due to growing demand for AI infrastructure and defense communications technology
RBOT Vicarious Surgical
Funded by Bill Gates and Vinod Khosla’s Ventures.
The Vicarious Surgical robot design intends to maximize visualization, precision, and control of instruments in robotic-assisted minimally invasive surgery.
It’s almost as if the surgeon is transported into the patient’s body.
SMTK SmartKem Inc
SmartKem is developing next-generation semiconductor materials that could change how wearable devices are built. The company recently signed a paid proof-of-concept deal with a global electronics company to create ultra-small curved smart wearables using its proprietary organic thin-film transistor (OTFT) technology combined with MicroLED displays.
Its technology is designed to solve major wearable challenges like lower battery use, brighter outdoor screens, durability, and extreme miniaturization.
SmartKem also developed what it says is the world’s first all-organic transistor biometric sensor, which could improve fingerprint and palm recognition on curved devices while helping detect fake fingerprints through advanced liveness detection.
VANI Vivani Medical
HEAVY INSIDER BUYING
VANI develops tiny implants that can slowly release medicine into the body for months or years.
Vivani Medical is a biotech and medical device company creating long-duration drug implants for obesity, diabetes, and chronic diseases. Its technology is designed to deliver therapies continuously over extended periods, potentially improving patient convenience and compliance.
Investors are particularly focused on its obesity treatment pipeline tied to GLP-1 drugs
VNRX VolitionRX Limited
VNRX is developing blood tests designed to detect cancer earlier and more easily.
VolitionRx is a diagnostics company developing blood-based cancer detection tests using nucleosome science. Its technology aims to identify cancer and other diseases through less invasive testing methods for both humans and animals.
Investors are interested in VNRX because early cancer detection remains one of the largest opportunities in healthcare diagnostics.
Real Creative Agency
Digital Marketing Experts
Daily helping our most valuable asset “YOU” since 2005.
